Construction high‐yield candidate influenza vaccine viruses in Vero cells by reassortment. Issue 11 (12th May 2016)

• Record Type: Journal Article
• Authors: Yu, Wei; Yang, Fan; Yang, Jinghui; Ma, Lei; Cun, Yina; Song, Shaohui; Liao, Guoyang
• Is Part Of: Journal of medical virology. Volume 88:Issue 11(2016)
• Page Start: 1914
• Page End: 1921
• Publication Date: 2016-05-12
• Subjects: influenza vaccine -- Vero cells adaption -- reassortment; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.24558
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract : Usage of influenza vaccine is the best choice measure for preventing and conclusion of influenza virus infection. Although it has been used of chicken embryo to produce influenza vaccine, following with WHO recommended vaccine strain, there were uncontrollable factors and its deficiencies, specially, during an influenza pandemic in the world. The Vero cells are used for vaccine production of a few strains including influenza virus, because of its homology with human, recommended by WHO. However, as known most of the influenza viruses strains could not culture by Vero cells. It was used two high‐yield influenza viruses adapted in Vero cells as donor viruses, such as A/Yunnan/1/2005Va (H3N2) and B/Yunnan/2/2005Va (B), to construct high‐yield wild influenza virus in Vero cells under antibody selection pressure. After reassortment and passages, it obtained the new Vaccine strains with A/Tianjin/15/2009Va (H1N1), A/Fujian/196/2009Va (H3N2) and B/Chongqing/1384/2010Va (B), which was not only completely keeping their original antigenic (HA and NA), but also grown well in Vero cells with high‐yield. All results of gene analysis and HA, HI shown that this reassortment method could be used to find new direction to product the influenza vaccine. J. Med. Virol. 88:1914–1921, 2016 . © 2016 Wiley Periodicals, Inc.